Form 8-K - Current report:
SEC Accession No. 0001493152-23-022920
Filing Date
2023-06-29
Accepted
2023-06-29 16:18:16
Documents
14
Period of Report
2023-06-27
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 58541
2 ex3-1.htm EX-3.1 23564
3 ex3-1_001.jpg GRAPHIC 3459
  Complete submission text file 0001493152-23-022920.txt   268550

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE pcsa-20230627.xsd EX-101.SCH 3060
5 XBRL LABEL FILE pcsa-20230627_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE pcsa-20230627_pre.xml EX-101.PRE 22389
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3435
Mailing Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076
Business Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076 443-776-3133
Processa Pharmaceuticals, Inc. (Filer) CIK: 0001533743 (see all company filings)

EIN.: 451539785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39531 | Film No.: 231057627
SIC: 2834 Pharmaceutical Preparations